Drug Trial Radar · NCT01876628
Adjunctive Clindamycin for Cellulitis: C4C Trial.
Last checked: Nov 19, 2026Latest source record: Aug 17, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
410
Actual
Start
Oct 2013
Primary completion
Dec 2015
Study completion Mar 2016
Sponsor
- Lead sponsor
- University Hospitals Bristol and Weston NHS Foundation TrustAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Bristol; Public Health England
- First posted
- Jun 12, 2013
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to see whether the addition of Clindamycin, a protein inhibiting antibiotic, to the standard antibiotic treatment of limb cellulitis, with Flucloxacillin, results in less tissue damage and a more rapid resolution of both systemic and local features, in a cost-effective manner. This study is a randomised controlled trial comparing Clindamycin with placebo.
Conditions
- Cellulitis
Interventions
FlucloxacillinDrug
Intravenous or oral Flucloxacillin. Minimum dose 500mg four times each day. Target duration 5 days less pre-recruitment beta-lactam duration.
ClindamycinDrug
Clindamycin dose 300mg four times each day for 2 days, within 48 hours of commencing flucloxacillin. Clindamycin is over-encapsulated and externally identical to placebo.
Placebo oral capsuleDrug
Placebo is externally identical to the over-encapsulated clindamycin and is taken four times each day for 2 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Improvement based on a composite of systemic and local featuresTime frame: Day 5
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Hospitals Bristol NHS Foundation Trust
Bristol, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.